◆ TICKERBASEVista interattiva →
◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

HomeTutte le azioni › SAILIFE · English version

Sai Life Sciences Limited (SAILIFE)

Storico di ricavi, utili e flussi di cassa dai bilanci ufficiali.

Healthcare · Wall Street (USA) · Ultimo aggiornamento: 2026-09-20

Sai Life Sciences Limited operates as a contract research, development, and manufacturing organization (CRDMO) in India and internationally. It offers medicinal chemistry, pharmacokinetics, clinical and commercial manufacturing, and process development services. The company was formerly known as SAI Advantium Pharma Limited and changed its name to Sai Life Sciences Limited in July 2006. Sai Life Sciences Limited was incorporated in 1999 and is headquartered in Hyderabad, India.

Dati chiave

Vedi grafici interattivi e bilanci completi →

Conto economico annuale

Conto economico2026-03-312025-03-312024-03-312023-03-31
Entrate totali₹21.4B₹16.6B₹14.6B₹12.0B
Utile lordo₹8.4B₹6.2B₹4.9B₹3.2B
Risultato Operativo (EBIT)₹4.7B₹2.7B₹1.8B₹768M
Reddito netto₹3.5B₹1.7B₹828M₹100M

Fonte: bilanci pubblici della società (SEC). Verificare su SEC EDGAR prima di fare affidamento su qualsiasi cifra.

Stati patrimoniali, flussi di cassa, dati trimestrali e indici completi nel visualizzatore interattivo di SAILIFE. /companies/us/SAILIFE

Aziende simili

Le informazioni di questo sito sono solo a scopo educativo e informativo; non costituiscono consulenza finanziaria. Non vengono pubblicati prezzi obiettivo né raccomandazioni.

English version →Tutte le azioni

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.